Acucela

Current News Coverage   1/20/10 Xconomy — "Acucela Enters Fast-Growth Phase As Macular Degeneration Drug Advances to Key Trial" > View More Recent Coverage

News

 

Conferences & Events

 

Israel Society for Vision & Eye Research (ISVER),

March 11-12, 2010, Israel

Robert David, M.D., will present initial data from a Phase 1 study assessing the safety and tolerability of ACU-4429 administration in healthy volunteers aged 55-80.

 

Current Press Releases

03/03/10 Acucela to Participate in the 16th Nomura Bio Conference

 

03/01/10 Acucela Announces Launch of its Japanese Web Site at www.Acucela.jp

 

02/02/10 Acucela to Present at the 12th Annual BIO CEO & Investor Conference

01/20/10 Acucela to Participate in Upcoming Joint Panel of the JEF and CSIS

01/13/10 Acucela Launches ENVISION Clarity Trial; Initiates Phase 2 Clinical Trial of Oral Visual Cycle Modulator in Patients with Dry Age-Related Macular Degeneration

 

11/23/09 Acucela Data in Dry AMD to be Highlighted at ISOPT

10/23/09 Acucela CEO and Founder Selected as One of Top 25 Innovators & Entrepreneurs

10/20/09 Acucela to Present at the Second Annual Boston Biotech R&D Conference

10/01/09 Acucela to Present at the BioJapan 2009 World Business Forum

09/09/09 Acucela Appoints New Member to Board of Directors

09/02/09 Acucela to Present at Rodman & Renshaw 11th Annual Healthcare Conference

06/23/09 Acucela’s Novel Visual Cycle Modulator Demonstrates Promise as a Treatment for Dry Age-Related Macular Degeneration

05/18/09 Acucela founder to present at BIO Business Forum

05/12/09 Acucela Presents Dry AMD Therapy Data at ARVO

04/28/09 Acucela Highlights Data to be Presented at ARVO

04/07/09 Acucela Founder to Speak at C21 BioVentures Conference

03/30/09 Acucela Hires Head of Clinical Development and Regulatory Affairs

02/19/09 Acucela Founder to Speak at Ophthalmology Conference

 

> View All Press Releases